Hints and tips:
Related Special Reports
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...Moderna: The pharmaceutical group will hold its annual investor day, when shareholders will be keen to learn more about how it plans to grow its business beyond the Covid-19 pandemic....
...The pharmaceutical company’s market capitalisation recently overtook Tesla thanks to investor enthusiasm over Mounjaro’s success. Earnings are expected to decrease by three cents to $2.11 a share....
...America....
...Pharma: Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie will also report earnings before the market opens....
...Friday’s decision comes after the state of New Hampshire failed in its bid to receive FDA permission because it did not identify a pharmaceutical wholesaler which could deliver the drugs....
...The US market is the engine of the global pharmaceutical industry. Its exceptionally high drug prices help deliver as much as three-quarters of the sector’s global profits....
...Gilead Sciences fell 10.5 per cent after the pharmaceutical company said its treatment for lung cancer failed to improve the survival of patients in its latest trial....
Drug developers raised $6bn in January, helped by a rebound in merger activity
...In contrast, pharmaceutical companies raised just $160mn for antibiotic research, a decline over the decade. Commercial activity and research in antibiotics have been in decline since the 1980s....
...An unanticipated boom in demand from China, Latin America, the Middle East and north Africa for alteplase, an off-patent drug used to treat strokes, has led to a shortage of supplies, according to Torsten...
And more on bad buybacks
...Large drugmakers have also underperformed, with the S&P 500 pharmaceutical sub-index heading for its worst performance relative to the broader S&P 500 in at least 20 years....
Americans account for 14% of users but their revenue contribution will be higher
...Another factor driving the growth of ETFs is the active ETF boom, said Bryan Armour, director of passive strategies research for North America at Morningstar Research Services....
...Max launched in the US in May 2023 in an attempt to challenge Netflix, Disney and Amazon in the streaming market, and in Latin America and the Caribbean earlier this year....
Legal battle between talent agency and Michael Kassan centres on jet flights and other spending
Americans’ interest in vaccinations has flagged despite efforts to boost uptake of latest jab
US state’s chancery court plays a key role in balancing interests of boards and investors
AI could be a game-changer for many of the tech giants
Also in this week’s newsletter, the Detroit Lions roar back and Real Madrid top football rich list
And yet, we’re struggling to care
...But Bryan Armour, director of passive strategies research for North America at Morningstar, said that on closer inspection a slightly different picture emerged....
Shares of start-up slide after reporting a $5.4bn annual loss and 10% cut to salaried payroll
International Edition